The SPDR S&P Biotech ETF (XBI) experienced a notable outflow of approximately $156.5 million, marking a 2.5% decrease in shares outstanding week-over-week, from 88,080,000 to 85,900,000. This change was reported in the week ending [insert date], and highlights a significant shift in investor sentiment towards this ETF.
Currently, XBI’s share price is $72.82, within a 52-week range that saw a low of $61.78 and a high of $141.50. Key components of XBI have seen minor gains today, with Global Blood Therapeutics Inc (GBT) up 0.7%, Seagen Inc (SGEN) up 2.1%, and Twist Bioscience Corp (TWST) higher by 1.8%.
